These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28035904)

  • 21. Magnetic particle imaging with tailored iron oxide nanoparticle tracers.
    Ferguson RM; Khandhar AP; Kemp SJ; Arami H; Saritas EU; Croft LR; Konkle J; Goodwill PW; Halkola A; Rahmer J; Borgert J; Conolly SM; Krishnan KM
    IEEE Trans Med Imaging; 2015 May; 34(5):1077-84. PubMed ID: 25438306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Processing of superparamagnetic iron contrast agent ferucarbotran in transplanted pancreatic islets.
    Zacharovová K; Berková Z; Jirák D; Herynek V; Vancová M; Dovolilová E; Saudek F
    Contrast Media Mol Imaging; 2012; 7(6):485-93. PubMed ID: 22991314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monodisperse magnetite nanoparticle tracers for in vivo magnetic particle imaging.
    Khandhar AP; Ferguson RM; Arami H; Krishnan KM
    Biomaterials; 2013 May; 34(15):3837-45. PubMed ID: 23434348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging.
    Heilmaier C; Lutz AM; Bolog N; Weishaupt D; Seifert B; Willmann JK
    Radiology; 2009 Dec; 253(3):724-33. PubMed ID: 19789232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
    Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
    Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic routes to magnetic nanoparticles for MPI.
    Kratz H; Eberbeck D; Wagner S; Taupitz M; Schnorr J
    Biomed Tech (Berl); 2013 Dec; 58(6):509-15. PubMed ID: 23950566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bimodal intravascular volumetric imaging combining OCT and MPI.
    Latus S; Griese F; Schlüter M; Otte C; Möddel M; Graeser M; Saathoff T; Knopp T; Schlaefer A
    Med Phys; 2019 Mar; 46(3):1371-1383. PubMed ID: 30657597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discriminating nanoparticle core size using multi-contrast MPI.
    Shasha C; Teeman E; Krishnan KM; Szwargulski P; Knopp T; Möddel M
    Phys Med Biol; 2019 Mar; 64(7):074001. PubMed ID: 30870817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2D Images Recorded With a Single-Sided Magnetic Particle Imaging Scanner.
    Grafe K; von Gladiss A; Bringout G; Ahlborg M; Buzug TM
    IEEE Trans Med Imaging; 2016 Apr; 35(4):1056-65. PubMed ID: 26701178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Labeling of mesenchymal stem cells for MRI with single-cell sensitivity.
    Ariza de Schellenberger A; Kratz H; Farr TD; Löwa N; Hauptmann R; Wagner S; Taupitz M; Schnorr J; Schellenberger EA
    Int J Nanomedicine; 2016; 11():1517-35. PubMed ID: 27110112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benchtop magnetic particle relaxometer for detection, characterization and analysis of magnetic nanoparticles.
    Garraud N; Dhavalikar R; Unni M; Savliwala S; Rinaldi C; Arnold DP
    Phys Med Biol; 2018 Sep; 63(17):175016. PubMed ID: 30095085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetorelaxometry procedures for quantitative imaging and characterization of magnetic nanoparticles in biomedical applications.
    Liebl M; Wiekhorst F; Eberbeck D; Radon P; Gutkelch D; Baumgarten D; Steinhoff U; Trahms L
    Biomed Tech (Berl); 2015 Oct; 60(5):427-43. PubMed ID: 26439595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in signal-to-noise ratios and contrast-to-noise ratios of hypervascular hepatocellular carcinomas on ferucarbotran-enhanced dynamic MR imaging.
    Park Y; Choi D; Kim SH; Kim SH; Kim MJ; Lee J; Lim JH; Lee WJ; Lim HK
    Eur J Radiol; 2006 Sep; 59(3):424-31. PubMed ID: 16920312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyglycerol-grafted superparamagnetic iron oxide nanoparticles: highly efficient MRI contrast agent for liver and kidney imaging and potential scaffold for cellular and molecular imaging.
    Arsalani N; Fattahi H; Laurent S; Burtea C; Vander Elst L; Muller RN
    Contrast Media Mol Imaging; 2012; 7(2):185-94. PubMed ID: 22434631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of commercial iron oxide-based MRI contrast agents with synthesized high-performance MPI tracers.
    Lüdtke-Buzug K; Haegele J; Biederer S; Sattel TF; Erbe M; Duschka RL; Barkhausen J; Vogt FM
    Biomed Tech (Berl); 2013 Dec; 58(6):527-33. PubMed ID: 23787462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2D model-based reconstruction for magnetic particle imaging.
    Knopp T; Biederer S; Sattel TF; Rahmer J; Weizenecker J; Gleich B; Borgert J; Buzug TM
    Med Phys; 2010 Feb; 37(2):485-91. PubMed ID: 20229857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spin-lock MR enhances the detection sensitivity of superparamagnetic iron oxide particles.
    Moonen RP; van der Tol P; Hectors SJ; Starmans LW; Nicolay K; Strijkers GJ
    Magn Reson Med; 2015 Dec; 74(6):1740-9. PubMed ID: 25470118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferucarbotran-loaded red blood cells as long circulating MRI contrast agents: first in vivo results in mice.
    Antonelli A; Pacifico S; Sfara C; Tamma M; Magnani M
    Nanomedicine (Lond); 2018 Apr; 13(7):675-687. PubMed ID: 29488423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI Meets MPI: a bimodal MPI-MRI tomograph.
    Vogel P; Lother S; Rückert MA; Kullmann WH; Jakob PM; Fidler F; Behr VC
    IEEE Trans Med Imaging; 2014 Oct; 33(10):1954-9. PubMed ID: 25291350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of semiquantitative liver perfusion assessment by ferucarbotran bolus injection in double-contrast hepatic MRI.
    Fischer MA; Donati OF; Reiner CS; Hunziker R; Nanz D; Boss A
    J Magn Reson Imaging; 2012 Jul; 36(1):168-76. PubMed ID: 22334302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.